microcirculation using the video microscopy tool. clinical trials

Empagliflozin's Microcirculatory Effects in Cardiogenic Shock: an Ancillary Pilot Study of the EMPASHOCK Trial

This study looks at how a drug called empagliflozin affects tiny blood vessels in people with a serious heart condition called cardiogenic shock. We're hoping to understand if it improves blood flow in these tiny vessels, which could help patients recover better.